Yi R. Hu, San L. Xing*, Chuan Chen, Ding Z. Shen and Jiu L. Chen Pages 208 - 221 ( 14 )
Background: Alzheimer's disease (AD) is the most common type of dementia and has a complex pathogenesis with no effective treatment. Energy metabolism disorders, as an early pathological event of AD,have attracted attention as a promising area of AD research. Codonopsis pilosula Polysaccharides are the main effective components of Codonopsis pilosula, which have been demonstrated to regulate energy metabolism.
Methods: In order to further study the roles and mechanisms of Codonopsis pilosula polysaccharides in AD, this study used an Aβ1-40-induced PC12 cells model to study the protective effects of Codonopsis pilosula polysaccharides and their potential mechanisms in improving energy metabolism dysfunction.
Results: The results showed that Aβ1-40 induced a decrease in PC12 cells viability, energy metabolism molecules (ATP, NAD+, and NAD+/NADH) and Mitochondrial Membrane Potential (MMP) and an increase in ROS. Additionally, it was found that Aβ1-40 increased CD38 expression related to NAD+ homeostasis, whereas Silent Information Regulation 2 homolog1 (SIRT1, SIRT3), Peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and SIRT3 activity were decreased. Codonopsis pilosula polysaccharides increased NAD+, NAD+/NADH, SIRT3, SIRT1, and PGC-1α related to NAD+, thus partially recovering ATP.
Conclusion: Our findings reveal that Codonopsis pilosula polysaccharides protected PC12 cells from Aβ1-40-induced damage, suggesting that these components of the Codonopsis pilosula herb may represent an early treatment option for AD patients.
Alzheimer's disease, Energy dysmetabolism, Codonopsis pilosula polysaccharide, NAD+, CD38, neurofibrillary tangles.
Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031, Shanghai Geriatric Institute of Chinese Medicine, Shanghai 200031